GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Optimind Pharma Corp (XCNQ:OMND) » Definitions » Investments And Advances

Optimind Pharma (XCNQ:OMND) Investments And Advances : C$0.05 Mil (As of Nov. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Optimind Pharma Investments And Advances?

Optimind Pharma's Investments And Advances for the quarter that ended in Nov. 2023 was C$0.05 Mil.

Optimind Pharma's quarterly Investments And Advances stayed the same from May. 2023 (C$0.05 Mil) to Aug. 2023 (C$0.05 Mil) and stayed the same from Aug. 2023 (C$0.05 Mil) to Nov. 2023 (C$0.05 Mil).

Optimind Pharma's annual Investments And Advances increased from . 20 (C$0.00 Mil) to Feb. 2022 (C$0.31 Mil) but then declined from Feb. 2022 (C$0.31 Mil) to Feb. 2023 (C$0.05 Mil).


Optimind Pharma Investments And Advances Historical Data

The historical data trend for Optimind Pharma's Investments And Advances can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Optimind Pharma Investments And Advances Chart

Optimind Pharma Annual Data
Trend Feb22 Feb23
Investments And Advances
0.31 0.05

Optimind Pharma Quarterly Data
Jun21 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23
Investments And Advances Get a 7-Day Free Trial 0.47 0.05 0.05 0.05 0.05

Optimind Pharma Investments And Advances Calculation

Investments And Advances includes all the non-current investments in affiliates, real estate, securities, etc.


Optimind Pharma (XCNQ:OMND) Business Description

Traded in Other Exchanges
N/A
Address
3000 - 77 King Street West, TD Centre, North Tower, PO Box 95, Toronto, ON, CAN, M5K 1G8
Optimind Pharma Corp is an emerging provider of psychedelic therapies for the masses. It helps people suffering from PTSD, Anxiety, Depression, and other mental illnesses and disabilities by providing ketamine-assisted-treatment and other psychedelic-enhanced-psychotherapy modalities.

Optimind Pharma (XCNQ:OMND) Headlines

No Headlines